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TITLE 
Survey of infection control in central venous catheters: Practice varies and is inconsistent with 
CDC Guidelines  
 
ABSTRACT  
Background 
Intensive care patients with a central venous catheter are at risk of catheter-related infection, 
which increases morbidity, mortality and healthcare costs. Infection control practices, 
including care of the intravenous administration sets and catheter site, are undertaken by 
nurses in an attempt to avoid infection. Although practice guidelines are available, anecdotal 
reports suggest that infection control practices vary between practitioners and institutions; 
however, current practice has not been formally surveyed. 
 
Aim 
To evaluate the current infection control practices for central venous catheter care and to 
compare these to evidence-based practice guidelines.  
 
Design 
Prospective, cross-sectional descriptive survey. 
 
Method 
Intensive care units (n=14) from Australia were surveyed about their infection control policies 
for central venous catheter care. Results were tabulated and compared with evidence-based 
practice guidelines (Guidelines for the Prevention of Intravascular Catheter-Related 
Infections, Centers for Disease Control [CDC], United States). 
 
Results 
A wide variety of responses were received regarding duration of administration set use for 
standard, parenteral nutrition and propofol infusions; ad hoc administration set connection 
technique; dressing frequency, materials and solutions; and barrier precautions used during 
procedures. There was inconsistent adherence to the CDC Guidelines. 
 
Conclusions 
There is currently great variation in the infection control approach to central venous catheter 
care. Greater adherence to existing CDC Guidelines would assist in the standardisation of best 
practice and facilitate evidence-based care. 
 
Keywords 
Nursing, Central venous catheter, Infection control.  
 
Descriptive Title 
Infection control procedures for central venous catheters: A survey of current nursing practice 
and comparison with the Centers for Disease Control Guidelines 
 
Short Title 
Infection control survey 
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SUMMARY STATEMENT 
What is already known on this topic? 
• Patients with central venous catheters are at risk of catheter-related infection which 
increases morbidity, mortality and healthcare costs 
• Many nursing practices attempt to minimize infective risk, although not all are 
supported by evidence 
• The Centers for Disease Control provides evidence-based practice guidelines for the 
prevention of infection and the care of central venous catheters 
What this study adds 
• This study provides data on the state of current nursing practice with regards to the 
infection control care of central venous catheters 
• This study provides information about the level of adherence by nurses to the Centers 
for Disease Control practice guidelines 
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BACKGROUND 
Many patients, particularly those in intensive care units (ICUs) have a central venous catheter 
(CVC) for the administration of fluid, nutrition and medication, or for intravascular 
monitoring. CVCs break the body’s natural defence barrier (the skin), and so put the patient at 
risk of catheter-related infection. Catheter related infection is devastating, with increased 
suffering and risk of death for patients and increased institutional costs due to the increased 
length and complexity of the hospital admission (Pittet et al. 1994). 
  
CVCs are ordered and inserted by physicians, however post-insertion catheter care is 
predominantly a nursing responsibility, providing an opportunity for nursing care to impact 
upon catheter infection rates. Many practices are used to minimize infection risk including 
procedures involving the intravenous administration sets and the catheter entry site. Varying 
levels of evidence exist for the efficacy of infection control procedures involving CVC care, 
however this is improving as more research is undertaken and published.  
 
The Centers for Disease Control (CDC) (Atlanta, Georgia, U.S.A.) is an important infection 
control body that has been influential in reviewing the evidence for effective infection 
prevention measures in many areas including intravascular therapy. The CDC published 
guidelines for the prevention of intravascular catheter-related infection in 1981 (CDC 1981), 
1996 (Pearson 1996), and most recently in 2002 (O'Grady et al. 2002). The Guidelines were 
developed by a multidisciplinary group of health professionals, are evidence-based, and 
provide recommendations for best practice. The goal of the Guidelines is to promote patient 
safety and to decrease preventable infections (O'Grady et al. 2003). A wide variety of related 
topics are covered including administration sets, injection ports, site care, and dressing 
regimes. In addition to general guidelines, specific guidelines are provided for various 
catheters including CVCs. 
 
Although the CDC Guidelines have existed for the past two decades, little is known about 
what practitioners actually do in clinical practice, and how closely clinical practice reflects the 
Guidelines. There is only one previous investigation into this area, a practice survey 
conducted in 1992 (Clemence et al. 1995). This survey involved a questionnaire distributed to 
nurses involved with central venous catheters in the hospital or home setting in the U.S.A. 
The investigated topics relevant to nurses included catheter site care (dressing type, 
frequency, antiseptic solutions, technique and protective garments). A range of practices were 
reported, and these were not always consistent with the evidence based Guidelines current at 
that time. This data supports anecdotal reports of wide procedural variation in the area of 
CVC infection control practice, however as it consists of only one study, undertaken in one 
country, and is now a decade old, we felt that an investigation into current practice was 
required. 
 
SIGNIFICANCE 
Central venous catheter infection control practice may vary between clinicians, and between 
healthcare organisational policies. Current levels of practice variation and the evidence-
practice relationship are unknown. Because of this, it is difficult to assess research and 
educational priorities and also to interpret the clinical significance of research findings.  
 
PURPOSE 
The purpose of the study was to address this problem and to provide a cross-sectional 
descriptive analysis of the current care of central venous catheters in the Australian ICU 
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population and to compare current practice with the evidence-based guidelines provided by 
the CDC.  
 
AIM 
To evaluate the current infection control practices regarding central venous catheter care in 
Australian intensive care units and to compare practice with evidence-based practice 
guidelines. 
 
RESEARCH METHOD 
 
Design 
Prospective, cross-sectional, descriptive survey. 
 
Research Questions 
1. What is the state of current nursing practice in regard to the duration of intravenous 
administration set use? 
 
2. What is the state of current nursing practice in regard to the infection control procedures 
used for intravenous administration sets and catheter site care? 
 
Sample 
Australian intensive care units (n=14), with representation from each State and Territory. 
 
Questionnaire 
A questionnaire was developed using the Centers for Disease Control (CDC) Guidelines for 
the Prevention of Intravascular Catheter-Related Infections (Pearson 1996; O'Grady et al. 
2002). The relevant Guideline sections used were: Hand hygiene; Aseptic technique during 
catheter insertion and care; Catheter site care; Catheter-site dressing regimes; Replacement of 
administration sets; and IV-injection ports. See Table 1. The questionnaire was validated by a 
reference group composed of expert ICU nurses who considered the research questions and 
the CDC Guidelines, and determined that the questionnaire accurately reflected the 
phenomena of interest.  
 
# Insert Table 1 
 
Procedure 
Intensive care units were contacted by telephone and invited to participate following an 
explanation of the survey aims. The questionnaire was then administered by telephone 
interview with the charge nurse or the senior nurse on duty in the participating intensive care 
units. Respondents were asked to provide answers that reflected unit policy or the 
predominant unit practice if no formal policy existed. The questionnaire elicited information 
about the duration of use of intravenous administration sets for standard infusions, total 
parenteral nutrition, lipid emulsion, and propofol infusions; infection control procedures used 
when connecting administration sets at an ad hoc time (at a time other than a routine set 
change); catheter site care (dressing frequency, type and solution); and barrier precautions 
used when replacing CVC administration sets or dressings. Demographic data was obtained to 
describe the ICU, patient population and the types of catheters used.  
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Ethical Considerations 
Institutional Ethics Committee approval was not required, as the practice survey had no 
impact on patient care or confidentiality. An explanation of the survey was provided over the 
telephone and completion of the questionnaire was assumed to imply consent. Confidentiality 
of individual and institutional responses was protected. 
 
Analysis  
Continuous variables were calculated for range, mean and standard deviation values. 
Categorical data was described using percentages and frequencies. Some responses were 
given in hours, days or frequencies per week. To allow comparison of this data, it was 
transformed into hourly data, for example procedures performed weekly (alternating every 
third then fourth day), were classified as a maximum of 96 hours. All analysis was undertaken 
used the Statistical Package for the Social Sciences version 10.0 (SPSS, Chicago, U.S.A.).  
A comparison was made of all responses with the relevant CDC Guidelines for the Prevention 
of Intravascular Catheter-Related Infections. These were last updated in 2002 (O'Grady et al. 
2002), although the 1996 version (Pearson 1996) was in place for the period of this survey. 
The minor relevant variations between the two versions of the Guidelines were accounted for 
during data analysis. 
 
RESULTS     
Sample 
All of the 14 Australian ICUs agreed to complete the questionnaire. All units were in public 
(government-operated) teaching hospitals in metropolitan or major regional areas. See Table 2 
for a comparison of the ICUs sampled. A combination of plain and antimicrobial catheters 
was used routinely in all units. 
 
# Insert Table 2 
 
Duration of intravenous administration set use 
Standard Infusions (crystalloid or crystalloid-based) 
A wide range of responses from 72-168 hours was given with a mean of 114.9 hours (SD 
43.3), which equates to just under 4 days of use. The most frequent responses were at the two 
extremes, with 5 units each reporting use of 72 hours and of 168 hours. See Table 3. The 
CDC Guidelines recommend that administration sets for these infusions are replaced no more 
frequently than every 72 hours.  
 
Total Parenteral Nutrition 
The response range was also wide, from 24-168 hours, with a mean reported maximum usage 
of 87.4 hours (SD 53.8), which equates to 3.6 days of use. The most commonly occurring 
response was 24 hours. See Table 3. ICUs who infused a non-lipid TPN solution (amino acids 
and dextrose) and a separate lipid emulsion reported identical usage timeframes for the 
administration sets. The CDC Guidelines recommend replacement of the administration sets 
used for non-lipid TPN no more frequently than every 72 hours, but a shorter 24-hour usage 
for lipid-containing TPN and for separate lipid emulsions.  
 
Propofol 
ICUs most frequently reported a 72-hour maximum usage for propofol administration sets, 
but again, the range of responses was wide, from 12 to 168 hours (mean 96.0, SD 50.5). See 
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Table 3. The CDC Guidelines recommend 24 hour administration set use for lipid emulsions 
such as propofol.  
 
# Insert Table 3 
 
Ad hoc Administration Set Change Procedure 
The majority of units (64%) reported that they swabbed the catheter-set connection when 
reconfiguring an administration set at a time other than the initial catheter insertion or a 
routine set change. The predominant technique was with a 70% alcohol pre-packaged swab. 
Alternately, others reported using chlorhexidine or alcoholic chlorhexidine. The 1996 
Guidelines recommended that the catheter hub be decontaminated before accessing the 
administration set, although a specific antiseptic was not stated. This procedure is no longer 
covered in the 2002 version of the Guidelines; however it is reasonable to generalise the 
recommendations for accessing injection ports to the accessing of the administration set, as 
both involve breaking the sterile circuit and potentially allow microbial contamination.  The 
Guidelines recommend that injection ports be cleaned immediately prior to use with 70% 
alcohol or an iodophor (e.g. Betadine, Purdue-Pharma L.P., Connecticut, U.S.A.).  
 
Catheter Site Care 
Dressing Material 
Semi-permeable transparent dressings were predominantly in use, with gauze dressings 
reported by only one unit.  See Table 4. The Guidelines equally recommend both of these 
dressings except in cases of severe diaphoresis or a bleeding, or oozing catheter site, in which 
case gauze dressings are preferentially recommended.  
 
# Insert Table 4 
 
Dressing Frequency 
A wide range of answers from 72 to 240 hours was reported for frequency of semi-permeable 
transparent dressing replacement, with a mode of 168 hours and mean of 142.2 hours (S.D. 
59.2). The one unit using gauze dressings replaced these at a maximum of 96 hourly intervals. 
See Table 4. The 1996 version of the CDC Guidelines considered dressing frequency to be an 
unresolved issue and gave no recommendations on the issue. The revised 2002 CDC 
Guidelines advocate 2nd daily replacement of gauze dressings and at least weekly replacement 
of semi-permeable transparent dressings. Many units commented that in addition to the 
routine timeframes, prn dressing changes were performed. Reasons for this were not 
requested. The Guidelines advise that dressings be additionally replaced if they are damp, 
loose, soiled or for site inspection.  
 
Dressing Solutions 
Most units reported use of antimicrobial products for post-insertion catheter site care. 
Reponses were almost evenly divided between five products. See Table 4. The 1996 CDC 
Guidelines did not include any recommendation for antimicrobial solution use during a CVC 
dressing. The revised 2002 Guidelines recommend that skin be disinfected during dressing 
changes with a 2% chlorhexidine-based preparation (for patients over 2 months of age), 
however a tincture of iodine, an iodophor (e.g. Betadine), or 70% alcohol are also 
acceptable. Use of a chlorhexidine impregnated sponge (Biopatch) is considered an 
unresolved issue by the CDC and no recommendations are made for its use.  
 
Barrier Precautions 
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Protective garments were worn in 57% of units to perform a dressing or a routine 
administration set change. Of these, plastic non-sterile aprons were most commonly used, 
followed by non-sterile and then sterile cloth gowns. All units reported wearing gloves (sterile 
57%, non-sterile 43%) to perform a CVC dressing or routine administration set change. Most 
units denied wearing a mask when performing CVC care although 14% of units reported 
wearing a mask for processes involving TPN. 
 
The CDC Guidelines do not advise the use of protective garments for CVC care and state 
masks are only to be used when admixing TPN, a procedure that is now generally performed 
in the pharmacy, not the ICU. The Guidelines recommend that gloves should be worn for a 
dressing change but that whether the gloves should be sterile or non-sterile is an unresolved 
issue. It is further noted that proper hand hygiene (with antiseptic containing soap and water 
or waterless alcohol-based gels or foams) must be attended to before and after the procedure, 
in addition to the use of gloves. The Guidelines’ recommendations for accessing 
administration sets include no reference to gloves, but do state the necessity for proper hand 
hygiene as above.  
 
DISCUSSION    
The survey found only two areas of infection control practice that were totally adherent to the 
CDC Guidelines: the duration of administration set use for standard infusions, and the type of 
catheter dressing. The 100% Guideline adherence regarding the use of general infusion 
administration sets is probably explained by the non-specific nature of the recommendation, 
that is, sets are recommended to be replaced no more frequently than at 72 hours, rather than 
giving a definite optimal duration of usage. The broad nature of this recommendation meant 
that although there was a large variation in the reported timeframes used (72-168 hours) they 
were all Guideline compliant. The results displayed two strong trends. Firstly, one third of 
ICUs reported replacing administration sets 72 hourly, which suggests the Guidelines may be 
misinterpreted as recommending a maximum rather than a minimum 72 hours of use. 
Conversely, another third of ICUs used administration sets for 168 hours (1 week). This  
timeframe is within the broad Guidelines, but is far removed from the well-researched ≤72 
hour interval, although reports are beginning to appear in the literature supporting longer 
administration set use (Raad et al. 2001; Rickard et al. 2002). There has been no published 
evaluation of the inherent efficacy of routinely replacing sets, although occasionally it is 
noted the practice may have no effect at any time interval (Maki et al. 1987; Ducharme et al. 
1988). Routinely changing administration sets before one week, or indeed at any time, may be 
a waste of time and resources. However, until a randomised controlled trial supports use to 
beyond one week, it would be prudent to limit administration-set use to this, rather than an 
unlimited time.   
 
Semi-permeable transparent dressings seem to be predominantly used in Australian ICUs, 
with all respondents reporting this dressing type, with the exception of one unit using gauze. 
The CDC equally recommends these two dressing types. This is consistent with a recent 
systematic review which found no difference between the products and attributed this to the 
small sample sizes studied to date (Gillies et al. 2003). In cases of diaphoresis or a bleeding, 
or oozing catheter site, gauze dressings are preferentially recommended by the CDC. Our 
survey did not seek to address these special circumstances and we cannot say whether 
Australian ICU nurses substitute gauze dressings in these cases.  
 
The study identified several infection control practices that were not in accordance with the 
CDC Guidelines. As such, they are areas for potential practice improvement. These areas 
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included: the duration of administration set use for TPN and lipid emulsions, including 
propofol; the procedure for ad hoc administration set changes; the frequency of dressing 
replacement; the antimicrobial solution used when dressing the catheter site; and barrier 
precautions used for catheter care. 
 
Many ICUs are currently replacing non-lipid TPN administration sets more frequently, and 
lipid sets (including propofol) less frequently than the Guidelines recommend. Historically all 
TPN was thought to carry a significantly higher microbial growth risk, but more recent data 
suggest that it is the lipid emulsion which is responsible (Didier et al. 1998; Matlow et al. 
1999). Our respondents did not differentiate between lipid emulsion-only solutions and other 
forms of TPN and rarely recognised that propofol, a frequently used ICU infusion, is a lipid 
emulsion. This is a potential avenue for further education and practice change.  
 
Many units reported complex infection control precautions for replacement of administration 
sets at routine intervals. In contrast, there was a lack of rigor for the approach used to replace 
administration sets intermittently. Administration-set configurations are not static throughout 
the catheterization period, but are manipulated frequently to add, remove or reconfigure 
infusions. A small majority of units reported that they used some type of decontaminant 
solution prior to performing an intermittent set change, usually a 70% alcohol pre-packaged 
wipe. This question also drew a large number of qualified responses with many respondents 
commenting that regardless of the presence/absence of a unit policy, decontamination was 
haphazardly performed. A thorough reading of the entire CDC Guidelines would allow a 
perception that hand hygiene and set decontamination should be attended in this situation. 
However there is no specific recommendation covering the procedure; this may at least 
partially explain the high level of practice uncertainty. To promote understanding and 
compliance by busy clinicians, it may be beneficial for future versions of the Guidelines to 
specifically outline the recommended procedure for intermittently connecting/disconnecting 
administration sets. 
 
The reported frequencies for dressing replacements were not all consistent with the current 
CDC Guidelines and a wide range of timeframes were quoted. This is perhaps due to the 1996 
Guidelines (in place during the study) giving no recommendation for CVC dressing 
frequency. In order to comply with the 2002 Guidelines, some units will need to change 
dressings more frequently than they are at present. Many respondents made the comment that 
additional dressings were performed as necessary, which is consistent with the Guidelines 
which recommend replacement if the dressing is damp, loosened or visibly soiled. The 
Guidelines for replacing semi-permeable transparent dressings are broad, giving a minimum 
(weekly) rather than a definitive time-frame. This is no doubt due to the limited amount of 
quality published research on the topic, with only one study (Rasero et al. 2000) cited by the 
Guidelines. 
 
The 1996 Guidelines also made no mention of the practice of decontaminating the catheter 
site during dressing replacements. Despite this, all units reported the practice as standard. The 
updated Guidelines now recommend that skin be disinfected during dressing changes with 
one of three solutions. Current practice, which involves a large variety of antimicrobial 
products, as well as saline, will need to be adapted accordingly. Although the Guidelines 
allow tincture of iodine, an iodophor, or 70% alcohol; 2% chlorhexidine is stated to be 
preferred. Chlorhexidine is supported by a meta-analysis of 4143 catheters published 
subsequent to the finalisation of the Guidelines which showed a halving of infection risk 
when chlorhexidine, rather than 10% povidine-iodine was used for insertional and ongoing 
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catheter site care (Chaiyakunapruk et al. 2002). The analysis included chlorhexidine at 
concentrations of 0.5-1.0% in alcohol and 0.5-2.0% in aqueous, which suggests that levels 
lower than the CDC recommended 2% are acceptable. The most recently available site-care 
product, chlorhexidine-impregnated sponges (Biopatch) have gained some market-share in 
Australia, despite their increased cost. The Guidelines state that there is inadequate research 
evidence at this time to recommend their use.  
 
The CDC Guidelines do not advocate protective garments for CVC dressings or 
administration set changes, yet a number of units wore these routinely. Under standard 
precautions, unless soiling with blood or body fluids is anticipated, gowning of any type is 
unnecessary and costly, and should be abandoned. All ICUs reported wearing sterile or non-
sterile gloves to perform dressings. Both glove types are acceptable for dressing replacement 
under the Guidelines, but are recommended purely as standard precautions, that is, to protect 
staff from possible body fluid exposure, rather than to prevent catheter infection.  Units 
currently using the more expensive sterile gloves should consider changing to the clean, non-
sterile variety. All units also reported wearing gloves to routinely replace administration sets. 
This is not a situation where exposure with blood or body fluids should be anticipated (unless 
dis/connecting a blood-product infusion), is not recommended by the Guidelines, and should 
be discontinued. A small number of units reported the wearing of masks whilst manipulating 
TPN administration sets. The CDC Guidelines do not recommend masks for this procedure 
and units should avoid this unnecessary practice. The Guidelines do recommend stringent 
attention to hand hygiene and an aseptic technique for all aspects of CVC care. 
 
The predominant findings of this study were the wide diversity of current practice involving 
infection control care of central venous catheters, and a lack of consistent adherence to the 
CDC Guidelines. These findings are consistent with a survey on central venous catheter care 
undertaken in the U.S.A. in 1992, which also found varied practice and divergence from CDC 
Guidelines (Clemence et al. 1995). Sub-optimal compliance with practice guidelines has also 
been observed in other infection control studies in the areas of hand hygiene, glove-wearing, 
needle recapping, and respiratory isolation (White et al. 1997; Tait et al. 2000; Harbath et al. 
2002; Stein et al. 2003).  
 
There are some limitations to our study. The sample size was small and limited to one 
country, and therefore cannot be interpreted as representative of ICU practice. However, the 
study did include participants from each Australian State and Territory and the results 
therefore provide some indication of Australian practice. The decision to administer the 
questionnaire to the senior nurse on duty and request information on the unit policy or 
predominant unit practice was based on the assumption that the nurse would know this 
information and that this would elicit an accurate answer. It is possible however, that 
responses actually reflected the individual’s practice bias or a perception of the “right” 
answer. The one previous practice survey on this topic involved a similar senior nursing 
sample; a practice questionnaire was distributed to attendees at a professional conference 
(Clemence et al. 1995). Results from self-report questionnaire surveys such as ours are 
subject to limitations, in that the behaviour reported may be different from that observed in 
practice. An observational design would have provided a more direct measure of infection 
control practice, although such studies require increased resources to undertake, and if 
subjects know that they are being observed, the Hawthorne effect causes modified infection 
control behaviour (Harbath et al. 2002). We did not have the resources to undertake a multi-
centre observational study, and instead used the questionnaire method, as have previous 
   10
studies seeking to describe elements of infection control practice (Alvaran et al. 1994; 
Clemence et al. 1995; Beaujean et al. 2000; Tait et al. 2000). 
 
Although the study results revealed a significant level of discrepancy between the CDC 
Guidelines and current practice, they do not explain why such discrepancies exist. The 
Guidelines are the most useful evidence-based document currently available for intravascular 
catheter care, are widely published and cited, and it is reasonable to expect that they should be 
reflected in clinical practice. Why is this not happening? Whilst we do not assume that all 
individual nurses would be familiar with the CDC Guidelines, those nurses who are 
responsible for the development or updating of unit policies should be. Additionally, it is 
important to periodically search the literature for relevant studies published subsequent to the 
Guidelines’ publication and adapt policy and practice accordingly.  
 
Our finding that there is a lack of adherence to evidence in unit policies almost certainly 
reflects a lack of resources or appropriate staffing positions to allow policies to be developed 
that reflect the current literature. Clinical policy development in Australia is often undertaken 
by nurses with advanced clinical skills, but limited experience in information retrieval and 
analysis. It would be beneficial for institutions to provide further support and training in 
policy development, and to encourage clinical nurses to develop policies in consultation with 
their local nurse researchers, academics, and other appropriate staff such as librarians. 
 
The use of CVCs in large numbers and for extended periods of time is a relatively new 
phenomenon, and some aspects of CVC care have not yet been fully investigated. The CDC 
Guidelines are based on the best available evidence, but in some cases recommendations 
cannot be given due to inadequate or conflicting research. This may be limiting the perceived 
usefulness of the Guidelines by clinicians. Nurses have embraced an evidence based culture 
relatively recently, and the knowledge-practice gap is a well-known problem (Retsas & Nolan 
1999; Pearson 2002). This may explain some of the practice variance observed. In recent 
years, antimicrobial catheters have been extremely effective in lowering catheter infection 
rates (Veenstra et al. 1999), and are used widely, although the CDC recommends their use 
only if infection rates remain a concern after all other basic precautions have been taken. In 
our study, almost all units reported using antimicrobial catheters as standard. Perhaps the use 
of these catheters has led to a complacent attitude to traditional anti-infective precautions, 
such as those covered in this study. Staff education about antimicrobial catheters should 
emphasize their role as an adjunct to, not a replacement for, basic principles of infection 
control.  
 
Our study assumed that clinical practice guidelines are beneficial to patients and that they 
should be reflected in good practice. It could perhaps be argued that reliance on guidelines 
detracts from individual professional accountability. Whilst ideally, all nurses would 
frequently review the research literature and incorporate relevant findings into practice; 
realistically, busy clinicians may not have the time, skills or inclination to do so. Clinical 
practice guidelines aim to facilitate evidence-based practice, decrease practice variation, and 
promote cost-effective care (O'Grady 2003). Guidelines developed by reputable organisations 
such as the CDC provide a useful tool for professionals to navigate the body of published 
evidence which continues to grow in both quantity and complexity. The CDC Guidelines 
provide guidance on care interventions that are effective both individually and when provided 
in total. Recent data from 2043 ICU patients showed a significant 57% reduction in catheter-
associated bloodstream infection in the 13 months after the provision of a comprehensive 
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educational intervention based on the CDC Guidelines (Warren et al. 2003). We contend that 
Guideline-compliant care should be interpreted as good care for central venous catheters. 
 
 
RECOMMENDATIONS 
1. That individual units review their policies and procedures for care of central venous 
catheters with particular reference to the CDC Guidelines. Our questionnaire may be a 
useful quality audit tool for practice review. 
2. That where diversity of practice is found, education and motivation for staff should be 
provided about the 2002 CDC Guidelines and these should be formalised in the 
relevant institutional policies. 
3. That further research is undertaken to resolve contentious or unsupported aspects of 
CVC care, and to evaluate effective ways to ensure clinicians are aware of, and 
comply with, evidence-based practice guidelines. The research should be of rigorous 
scientific design and execution, including large multi-site, randomised controlled trials 
where appropriate. Specific areas requiring further investigation include:  
• The optimal maximum duration of administration set use. 
• The decontamination technique to be used when connecting administration sets 
on a routine or ad hoc basis. 
• The optimal frequency for CVC dressing replacement. 
• The efficacy of barrier precautions when manipulating administration sets or 
site dressings. 
• The efficacy of chlorhexidine-impregnated sponges for CVC site care.  
 
CONCLUSION 
We conclude that there is a significant amount of current practice variation in the infection 
control methods used for CVC care, and that practice does not always reflect the CDC 
Guidelines for the Prevention of Intravascular Catheter-Related Infections. Future research 
should endeavour to address the evidence gaps in the area of central venous catheter care, and 
also investigate ways to improve clinician awareness of, and adherence to, evidence-based 
practice guidelines. A greater degree of homogeneity in CVC infection control practice will 
assist in the prevention of catheter-related infection, ensure best practice care, promote the 
judicious use of health budgets, ease the transition of staff between healthcare organisations, 
and facilitate multi-centre research projects. 
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Table 1. Questionnaire for comparison of current practice with CDC Guidelines  
Infection Control 
Procedure 
Current Practice CDC Guidelines (O'Grady et al. 2002) Level of 
Evidence* 
Duration of 
administration set use 
for standard infusions  
 IX.A.1. “Replace administration sets, including secondary sets and 
add-on devices, no more frequently than at 72-hour 
intervals…”(O'Grady et al. 2002,p.15)  
IA 
Duration of 
administration set use 
for total parenteral 
nutrition infusions 
 IX.A.2. “If the solution contains only dextrose and amino acids, the 
administration set does not need to be replaced more frequently than 
every 72 hours”(O'Grady et al. 2002,p.15)  
II 
Duration of 
administration set use 
for lipid emulsion 
infusions 
 IX.A.2. “Replace tubing used to administer blood, blood products, or 
lipid emulsions (those combined with amino acids and glucose in a 
3-in-1 admixture or infused separately) within 24 hours of initiating 
the infusion”(O'Grady et al. 2002,p.15) 
IB 
Duration of 
administration set use 
for propofol 
infusions 
 “IX.A.3. “Replace tubing used to administer propofol infusions every 
…12 hours, … as per the manufacturer’s recommendation (for 
infusions)”(O'Grady et al. 2002,p.15)  
IA 
Decontamination of 
CVC hub-
administration set 
connection prior to 
every connection/ 
disconnection of an 
administration set 
 X.A. Clean injection ports with 70% alcohol or an iodophor before 
accessing the system”(O'Grady et al. 2002,p.15)  
 
III.A. “Observe proper hand-hygiene procedures either by washing 
hands with conventional antiseptic-containing soap and water or 
with waterless alcohol-based gels or foams. Observe hand hygiene 
before and after…accessing…(or) repairing… an intravascular 
catheter”(O'Grady et al. 2002,p.13)  
IA 
 
 
IA 
CVC dressing type  VII.A. “Use either sterile gauze or sterile, transparent, semi-
permeable dressing to cover the catheter site”(O'Grady et al. 
2002,p.14) 
 
VII.C. “If the patient is diaphoretic, or if the site is bleeding or 
oozing, a gauze dressing is preferable to a transparent, semi-
permeable dressing”(O'Grady et al. 2002,p.14) 
 
VI.D. “No recommendation can be made for the use of chlorhexidine 
sponge dressings to reduce the incidence of infection”(O'Grady et al. 
2002,p.18) 
 
VI.E. Do not use chlorhexidine sponge dressings in neonates aged 
<7 days or of gestational age <26 weeks”(O'Grady et al. 2002,p.18) 
IA 
 
 
II 
 
 
 
Unresolved 
issue 
 
II 
Maximum time that 
CVC dressings are 
left intact 
 VI.C.1 “Replace catheter-site dressing when it becomes damp, 
loosened, or soiled or when inspection of the site is 
necessary”(O'Grady et al. 2002,p.17) 
 
VI.C.2 “Replace dressings used on short-term CVC sites every 2 
days for gauze dressings and at least every 7 days for transparent 
dressings, except in those paediatric patients in which the risk of 
dislodging the catheter outweighs the benefit of changing the 
dressing”(O'Grady et al. 2002,p.17) 
IA 
 
 
IB 
Solution used for 
CVC site care 
 VI.A.1. Disinfect clean skin with an appropriate antiseptic…during 
dressing changes. Although a 2% chlorhexidine-based preparation is 
preferred, tincture of iodine, an iodophor, or 70% alcohol can be 
used”(O'Grady et al. 2002,p.14)  
 
VI.A.2. No recommendation can be made for the use of chlorhexidine 
in infants aged < 2 months.(O'Grady et al. 2002,p.14) 
IA 
 
 
 
 
Unresolved 
issue 
Barrier precautions 
are used for CVC 
care 
 IV.C. “Wear clean or sterile gloves when changing the dressing on 
intravascular catheters”(O'Grady et al. 2002,p.14) 
 
III.B. “Use of gloves does not obviate the need for hand 
hygiene”(O'Grady et al. 2002,p.13) 
IC 
 
 
IA 
*Level of Evidence: IA. Strongly supported for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies. IB. 
Strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies, and a strong theoretical rationale. IC. 
Required by (U.S.) state or federal regulations, rules or standards. II. Suggested for implementation and supported by suggestive clinical or epidemiologic studies 
or a theoretical rationale. Unresolved issue. Represents an unresolved issue for which evidence is insufficient or no consensus regarding efficacy exists. 
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Table 2. Characteristics of participating ICUs  
Size of ICU Patients admitted per year 
Beds Sample Patients Sample 
≤ 6 3 ≤500 4 
7-14 6 501-1199 3 
15-24 5 1200-1500 7 
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Table 3. Reported maximum duration of intravenous administration set use compared 
with the CDC Guidelines 
Infusion Type Set Usage* 
(hours) 
No of ICUs % 
Standard ≥ 72 14 100 
 < 72 0 0 
TPN ≥ 72  10 71 
 < 72 4 29 
Lipid ≤ 24  10 71 
 > 24 4 29 
Propofol ≤ 12  2 14 
 > 12 12 86 
* Shaded cells represent the recommended duration of administration set use as per the CDC Guidelines for the 
Prevention of Intravascular Catheter-Related Infections. Respondent answers in these shaded rows represent 
Guideline-compliant practice. 
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Table 4. Reported frequency and type of CVC site care compared with the CDC 
Guidelines 
   No of ICUs % 
Transparent semi-permeable 13 93 Type 
Gauze 1 7 
≤ weekly 11 85 Frequency Transparent semi-
permeable > weekly 2 15 
≤ 48 hrs 0 0  Gauze 
> 48 hrs 1 100 
Solution 2% chlorhexidine 0 0 
 Tincture of iodine/iodophor 3 21 
 70% alcohol 3 21 
 70% alcohol/0.5% chlorhexidine 3 21 
 Saline 3 21 
 Chlorhexidine sponges 2 14 
* Shaded cells represent the recommended CVC site care as per the CDC Guidelines for the Prevention of 
Intravascular Catheter-Related Infections. Respondent answers in these shaded rows represent Guideline-
compliant practice. 
 
